Foresite Capital surpassed its $650 million goal to close its largest fund yet, with $668 million in capital commitments. While the firm doesn't limit itself by therapeutic area...
Rhythm Pharmaceuticals has topped its expectations in its IPO, selling more shares—at a higher price—than expected when it announced its intention to go public a few weeks back.